ZWJ Investment Counsel’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-71,977
| Closed | -$9.43M | – | 157 |
|
2019
Q2 | $9.43M | Buy |
71,977
+15,177
| +27% | +$1.99M | 0.74% | 48 |
|
2019
Q1 | $7.68M | Buy |
56,800
+6,185
| +12% | +$836K | 0.63% | 49 |
|
2018
Q4 | $4.93M | Sell |
50,615
-12,987
| -20% | -$1.26M | 0.46% | 56 |
|
2018
Q3 | $8.84M | Buy |
63,602
+433
| +0.7% | +$60.2K | 0.72% | 47 |
|
2018
Q2 | $7.84M | Buy |
63,169
+1,751
| +3% | +$217K | 0.68% | 50 |
|
2018
Q1 | $6.85M | Buy |
61,418
+2,373
| +4% | +$265K | 0.62% | 52 |
|
2017
Q4 | $7.06M | Sell |
59,045
-24,003
| -29% | -$2.87M | 0.56% | 49 |
|
2017
Q3 | $11.7M | Buy |
83,048
+20,721
| +33% | +$2.91M | 0.91% | 43 |
|
2017
Q2 | $7.58M | Buy |
62,327
+60,206
| +2,839% | +$7.32M | 0.61% | 49 |
|
2017
Q1 | $257K | Buy |
+2,121
| New | +$257K | 0.02% | 270 |
|